patient experience

D.J. Stewart
D.J. Stewart
D.J. Stewart has a few choice words for glioblastoma, which he’s faced with defiant optimism. Now he’s joining the larger rebellion against brain cancer.
D.J. Stewart
Roslyn Singleton
Roslyn Singleton
As she faces glioblastoma, Roslyn Singleton finds strength in her faith and family.
Roslyn Singleton
Bruce Stahlman
Bruce Stahlman
Bruce and Kelly Stahlman found strength in gratitude as they raised, and then lost, twin boys with disabilities. They have faced Bruce’s glioblastoma with the same relentless spirit.
Bruce Stahlman
Justin Charrette
Justin Charrette
After his glioblastoma diagnosis, Justin Charrette was overwhelmed, physically and mentally. With help from his wife, Courtney, he is feeling stronger and more hopeful about the future.
Justin Charrette
Wade Lewis
Wade Lewis
When glioblastoma led to his early retirement, Wade Lewis put his energy into helping others affected by the same diagnosis.
Wade Lewis
Steve Davis
Steve Davis
Following his glioblastoma diagnosis, Steve Davis learned how to savor both the singular and mundane moments of life.
Steve Davis
Ira Bornstein
Ira Bornstein
Ira and Sandy Bornstein have always lived an active lifestyle. Since Ira’s glioblastoma diagnosis, they have stayed committed to doing what they love most.
Ira Bornstein
Lynn Oxenberg
Lynn Oxenberg
Lynn Oxenberg is used to standing out in a crowd. Since her glioblastoma diagnosis, she has used her influence to help others affected by brain tumors.
Lynn Oxenberg

our culture

emboldened to innovate
emboldened to innovate
Novocure created a new way to treat some of the most aggressive forms of cancer. Six employees share how they harness our founding spirit to deliver innovative solutions.
emboldened to innovate
acting with empathy
acting with empathy
We put ourselves in the shoes of our patients, their families, health care providers, researchers and our colleagues as we strive to change the way cancer is treated. Six Novocure employees share their stories of empathy.
acting with empathy
honing our focus
honing our focus
To achieve our patient-forward aspirations, we must be intentional in how we spend our time, energy and resources. Six Novocure employees share their strategies for focus.
honing our focus
calling on courage
calling on courage
We stand alongside our patients and stand up for them by challenging the status quo. Six Novocure employees share their stories of courage.
calling on courage
building trust
building trust
Our dedication to developing and maintaining trusting relationships helps us make a difference in the lives of cancer patients. Six Novocure employees share how they build trust.
building trust
driven to make an impact
driven to make an impact
Our passion for making a difference in the lives of cancer patients fuels us in our work and guides us in our decision-making. Six Novocure employees share their stories of drive.
driven to make an impact
delivering excellence
delivering excellence
Our Global Supply Chain team is building the backbone for our anticipated growth.
delivering excellence
Novocure named a top workplace in New Hampshire
Novocure named a top workplace in New Hampshire
Novocure, a global oncology company with U.S. operations based in New Hampshire, has been recognized as a top employer in the Granite State for the second year in a row.
Novocure named a top workplace in New Hampshire

features

a Q&A with our founder
a Q&A with our founder
Novocure founder Professor Yoram Palti, recipient of the 2022 Israel Prize for excellence in entrepreneurship and technological innovation, reflects on his discovery of Tumor Treating Fields.
a Q&A with our founder
Novocure pledges $250K to Families First Health and Support Center
Novocure pledges $250K to Families First Health and Support Center
We committed the lead corporate gift to the capital campaign for a New Hampshire community health center’s new home.
Novocure pledges $250K to Families First Health and Support Center
lighting the world blue
lighting the world blue
Mesothelioma Awareness Day takes place annually in the U.S. on Sept. 26.
lighting the world blue
standing with the brain tumor community
standing with the brain tumor community
As a global oncology company focusing on improving survival in some of the most aggressive forms of cancer, Novocure proudly stands with the brain tumor community during May for Brain Tumor Awareness Month (BTAM).
standing with the brain tumor community
Ignace Vergote, Novocure Clinical Trial Investigator
Ignace Vergote, Novocure Clinical Trial Investigator
Professor Ignace Vergote has dedicated his 32-year career to investigating treatment options and striving to improve survival in gynecologic cancers. Among gynecologic cancers, ovarian cancer is the deadliest, representing the fifth most common cause of cancer death among women in the United States. Five-year survival in ovarian cancer has slowly increased from 34 percent in 1975 to 47 percent today.
Ignace Vergote, Novocure Clinical Trial Investigator